President Donald Trump has announced a series of actions aimed at reducing costs and increasing access to In Vitro Fertilization (IVF) and fertility treatments. The White House has released a comprehensive plan that includes a deal with EMD Serono to lower prices on fertility drugs, as well as negotiations with German Merck to cut IVF treatment costs. Trump emphasized the goal of making IVF more affordable for American families and touted potential government guidance to encourage employers to offer fertility coverage. Despite these announcements, critics note that the plans do not include new funding or coverage requirements. As part of the initiative, the Trump administration expects these changes will significantly decrease the costs of IVF drugs and make them available at discounted rates through a new pharmacy partnership. This effort is framed as part of a broader strategy to increase the birth rate in the U.S. and support families looking to expand.